Canada based Queen’s University has initiated a cutting edge study on psychedelic drugs. The University said it will be carrying out the research in collaboration with other institutions to study the efficacy and use of psychedelic drugs on people fighting serious conditions like severe depression and post-traumatic stress disorder (PTSD).
This study will be led by David Clements, Executive Director of Psychedelic Research at the university’s Faculty of Health Sciences. Clements says the research is in its initial stages of gathering studies and research from around the world.
“We are in the foundational stages of what we think is exciting. What’s unique is the kind of unit we’re setting up, and how we’re trying to approach what Queen’s contributions will be in a rapidly developing field,” said Clements.
According to Clements, Canada is part of a global movement which has scientists around the world interested in using psychedelic drugs to test whether they can be of benefits to people with serious health problems.
“You can’t do that everywhere, but you can do that in Canada. We have an opportunity to be on the cutting edge of science,” added Clements.
